AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-11-15
著者
-
Ostermann H.
Medizinische Klinik Und Poliklinik Iii Klinikum Grosshadern Der Universitat Munchen
-
Karsch C.
University Hospital Carl Gustav Carus At The Technical University Dresden
-
LINDNER L.
Medizinische Klinik und Poliklinik III, Klinikum Grosshadern der Universitat Munchen
-
HIDDEMANN W.
Medizinische Klinik und Poliklinik III, Klinikum Grosshadern der Universitat Munchen
-
KIANI A.
University Hospital Carl Gustav Carus at the Technical University Dresden
-
WURFEL M.
University Hospital Carl Gustav Carus at the Technical University Dresden
-
ILLMER T.
University Hospital Carl Gustav Carus at the Technical University Dresden
-
PLATZBECKER U.
University Hospital Carl Gustav Carus at the Technical University Dresden
-
EHNINGER G.
University Hospital Carl Gustav Carus at the Technical University Dresden
-
SCHLEYER E.
University Hospital Carl Gustav Carus at the Technical University Dresden
-
Lindner L.
Medizinische Klinik Und Poliklinik Iii Klinikum Grosshadern Der Universitat Munchen
-
Schleyer E.
Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden
-
Hiddemann W.
Medizinische Klinik Und Poliklinik Iii Klinikum Grosshadern Der Universitat Munchen
-
Ehninger G.
Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden
関連論文
- AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity
- High-performance liquid chromatography method with ultraviolet detection for the quantification of the BCR-ABL inhibitor nilotinib (AMN107) in plasma, urine, culture medium and cell preparations
- Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations